RUNX1_HUMAN - dbPTM
RUNX1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RUNX1_HUMAN
UniProt AC Q01196
Protein Name Runt-related transcription factor 1
Gene Name RUNX1
Organism Homo sapiens (Human).
Sequence Length 453
Subcellular Localization Nucleus.
Protein Description Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. The heterodimers bind to the core site of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters (Probable). Essential for the development of normal hematopoiesis. [PubMed: 17431401 Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the BLK promoter]
Protein Sequence MRIPVDASTSRRFTPPSTALSPGKMSEALPLGAPDAGAALAGKLRSGDRSMVEVLADHPGELVRTDSPNFLCSVLPTHWRCNKTLPIAFKVVALGDVPDGTLVTVMAGNDENYSAELRNATAAMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKITVDGPREPRRHRQKLDDQTKPGSLSFSERLSELEQLRRTAMRVSPHHPAPTPNPRASLNHSTAFNPQPQSQMQDTRQIQPSPPWSYDQSYQYLGSIASPSVHPATPISPGRASGMTTLSAELSSRLSTAPDLTAFSDPRQFPALPSISDPRMHYPGAFTYSPTPVTSGIGIGMSAMGSATRYHTYLPPPYPGSSQAQGGPFQASSPSYHLYYGASAGSYQFSMVGGERSPPRILPPCTNASTGSALLNPSLPNQSDVVEAEGSHSNSPTNMAPSARLEEAVWRPY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3 (in isoform 8)Phosphorylation-3.6326552605
5 (in isoform 8)Phosphorylation-10.0026552605
8PhosphorylationMRIPVDASTSRRFTP
CCCCCCCCCCCCCCC
23.5826074081
9PhosphorylationRIPVDASTSRRFTPP
CCCCCCCCCCCCCCC
28.1526074081
9 (in isoform 8)Phosphorylation-28.1526552605
10PhosphorylationIPVDASTSRRFTPPS
CCCCCCCCCCCCCCC
20.9726074081
12 (in isoform 8)Phosphorylation-39.2926552605
13 (in isoform 8)Phosphorylation-13.4626552605
14PhosphorylationASTSRRFTPPSTALS
CCCCCCCCCCCCCCC
32.2629255136
17PhosphorylationSRRFTPPSTALSPGK
CCCCCCCCCCCCCCC
27.7623401153
17 (in isoform 9)Phosphorylation-27.7615302935
18PhosphorylationRRFTPPSTALSPGKM
CCCCCCCCCCCCCCH
37.0723401153
19UbiquitinationRFTPPSTALSPGKMS
CCCCCCCCCCCCCHH
15.4721890473
21PhosphorylationTPPSTALSPGKMSEA
CCCCCCCCCCCHHCC
29.1929255136
24AcetylationSTALSPGKMSEALPL
CCCCCCCCHHCCCCC
42.5119608861
24UbiquitinationSTALSPGKMSEALPL
CCCCCCCCHHCCCCC
42.5119608861
26PhosphorylationALSPGKMSEALPLGA
CCCCCCHHCCCCCCC
24.1728787133
41 (in isoform 8)Phosphorylation-14.3515302935
43AcetylationAGAALAGKLRSGDRS
HHHHHHHHCCCCCCC
34.8119608861
43UbiquitinationAGAALAGKLRSGDRS
HHHHHHHHCCCCCCC
34.8123000965
43 (in isoform 1)Ubiquitination-34.8121890473
43 (in isoform 2)Ubiquitination-34.8121890473
43 (in isoform 3)Ubiquitination-34.8121890473
43 (in isoform 4)Ubiquitination-34.8121890473
43 (in isoform 5)Ubiquitination-34.8121890473
43 (in isoform 6)Ubiquitination-34.8121890473
46PhosphorylationALAGKLRSGDRSMVE
HHHHHCCCCCCCCEE
56.3230576142
46 (in isoform 7)Ubiquitination-56.3221890473
46 (in isoform 9)Ubiquitination-56.3221890473
50PhosphorylationKLRSGDRSMVEVLAD
HCCCCCCCCEEHHHC
31.7430576142
51AcetylationLRSGDRSMVEVLADH
CCCCCCCCEEHHHCC
2.8719608861
51SulfoxidationLRSGDRSMVEVLADH
CCCCCCCCEEHHHCC
2.8721406390
51UbiquitinationLRSGDRSMVEVLADH
CCCCCCCCEEHHHCC
2.8719608861
51 (in isoform 8)Ubiquitination-2.87-
57UbiquitinationSMVEVLADHPGELVR
CCEEHHHCCCCCEEE
44.3321890473
58UbiquitinationMVEVLADHPGELVRT
CEEHHHCCCCCEEEC
27.0221890473
58 (in isoform 10)Ubiquitination-27.0221890473
65PhosphorylationHPGELVRTDSPNFLC
CCCCEEECCCCCCEE
33.0928450419
67PhosphorylationGELVRTDSPNFLCSV
CCEEECCCCCCEEEE
22.5628450419
70UbiquitinationVRTDSPNFLCSVLPT
EECCCCCCEEEECCC
9.1521890473
70AcetylationVRTDSPNFLCSVLPT
EECCCCCCEEEECCC
9.1519608861
70UbiquitinationVRTDSPNFLCSVLPT
EECCCCCCEEEECCC
9.1523000965
70 (in isoform 8)Ubiquitination-9.1521890473
83UbiquitinationPTHWRCNKTLPIAFK
CCCCCCCCCCCEEEE
55.8829967540
83 (in isoform 11)Ubiquitination-55.8821890473
84PhosphorylationTHWRCNKTLPIAFKV
CCCCCCCCCCEEEEE
24.6328555341
90UbiquitinationKTLPIAFKVVALGDV
CCCCEEEEEEEECCC
27.12-
101UbiquitinationLGDVPDGTLVTVMAG
ECCCCCCCEEEEEEC
25.9923000965
110UbiquitinationVTVMAGNDENYSAEL
EEEEECCCCCHHHHH
44.6029967540
110 (in isoform 8)Ubiquitination-44.60-
125AcetylationRNATAAMKNQVARFN
HHHHHHHHHHHHHHC
39.2325953088
125UbiquitinationRNATAAMKNQVARFN
HHHHHHHHHHHHHHC
39.2323000965
139UbiquitinationNDLRFVGRSGRGKSF
CCEEEECCCCCCCEE
30.5423000965
140UbiquitinationDLRFVGRSGRGKSFT
CEEEECCCCCCCEEE
27.2423000965
144AcetylationVGRSGRGKSFTLTIT
ECCCCCCCEEEEEEE
40.8215138260
144UbiquitinationVGRSGRGKSFTLTIT
ECCCCCCCEEEEEEE
40.82-
145O-linked_GlycosylationGRSGRGKSFTLTITV
CCCCCCCEEEEEEEE
26.7027655845
145PhosphorylationGRSGRGKSFTLTITV
CCCCCCCEEEEEEEE
26.7055456607
147PhosphorylationSGRGKSFTLTITVFT
CCCCCEEEEEEEEEC
30.0455456609
149PhosphorylationRGKSFTLTITVFTNP
CCCEEEEEEEEECCC
16.1455456605
151PhosphorylationKSFTLTITVFTNPPQ
CEEEEEEEEECCCCC
12.34-
152UbiquitinationSFTLTITVFTNPPQV
EEEEEEEEECCCCCC
5.0123000965
152 (in isoform 8)Ubiquitination-5.01-
158UbiquitinationTVFTNPPQVATYHRA
EEECCCCCCEEEEEE
38.4423000965
158 (in isoform 7)Ubiquitination-38.4421890473
164UbiquitinationPQVATYHRAIKITVD
CCCEEEEEEEEEECC
27.8221890473
167UbiquitinationATYHRAIKITVDGPR
EEEEEEEEEECCCCC
31.19-
169PhosphorylationYHRAIKITVDGPREP
EEEEEEEECCCCCCC
13.9324043423
182AcetylationEPRRHRQKLDDQTKP
CCCCCHHHCCCCCCC
54.5725953088
182UbiquitinationEPRRHRQKLDDQTKP
CCCCCHHHCCCCCCC
54.5723000965
187PhosphorylationRQKLDDQTKPGSLSF
HHHCCCCCCCCCCCH
46.3223186163
188AcetylationQKLDDQTKPGSLSFS
HHCCCCCCCCCCCHH
41.5723749302
188UbiquitinationQKLDDQTKPGSLSFS
HHCCCCCCCCCCCHH
41.5723000965
188 (in isoform 1)Ubiquitination-41.5721890473
188 (in isoform 2)Ubiquitination-41.5721890473
188 (in isoform 3)Ubiquitination-41.5721890473
188 (in isoform 4)Ubiquitination-41.5721890473
191PhosphorylationDDQTKPGSLSFSERL
CCCCCCCCCCHHHHH
29.3923401153
191 (in isoform 9)Ubiquitination-29.3921890473
193PhosphorylationQTKPGSLSFSERLSE
CCCCCCCCHHHHHHH
28.5523401153
194 (in isoform 8)Ubiquitination-12.18-
195PhosphorylationKPGSLSFSERLSELE
CCCCCCHHHHHHHHH
20.5930576142
196UbiquitinationPGSLSFSERLSELEQ
CCCCCHHHHHHHHHH
56.4823000965
197UbiquitinationGSLSFSERLSELEQL
CCCCHHHHHHHHHHH
42.1723000965
199PhosphorylationLSFSERLSELEQLRR
CCHHHHHHHHHHHHH
46.484114501
202UbiquitinationSERLSELEQLRRTAM
HHHHHHHHHHHHHHH
43.4421890473
203UbiquitinationERLSELEQLRRTAMR
HHHHHHHHHHHHHHH
53.5521890473
203 (in isoform 10)Ubiquitination-53.5521890473
206MethylationSELEQLRRTAMRVSP
HHHHHHHHHHHHHCC
35.11-
207PhosphorylationELEQLRRTAMRVSPH
HHHHHHHHHHHHCCC
20.5523927012
209UbiquitinationEQLRRTAMRVSPHHP
HHHHHHHHHHCCCCC
4.2623000965
209 (in isoform 8)Ubiquitination-4.26-
210MethylationQLRRTAMRVSPHHPA
HHHHHHHHHCCCCCC
24.25-
212PhosphorylationRRTAMRVSPHHPAPT
HHHHHHHCCCCCCCC
14.2523401153
215UbiquitinationAMRVSPHHPAPTPNP
HHHHCCCCCCCCCCC
24.4921890473
215UbiquitinationAMRVSPHHPAPTPNP
HHHHCCCCCCCCCCC
24.4921890473
215 (in isoform 8)Ubiquitination-24.4921890473
219PhosphorylationSPHHPAPTPNPRASL
CCCCCCCCCCCCCCC
37.4923927012
223MethylationPAPTPNPRASLNHST
CCCCCCCCCCCCCCC
43.37-
225PhosphorylationPTPNPRASLNHSTAF
CCCCCCCCCCCCCCC
30.8628450419
229PhosphorylationPRASLNHSTAFNPQP
CCCCCCCCCCCCCCC
21.9824260401
230PhosphorylationRASLNHSTAFNPQPQ
CCCCCCCCCCCCCCC
27.9328450419
238PhosphorylationAFNPQPQSQMQDTRQ
CCCCCCCHHCCCCCC
34.0123312004
238 (in isoform 3)Phosphorylation-34.0126714015
239PhosphorylationFNPQPQSQMQDTRQI
CCCCCCHHCCCCCCC
28.4532645325
249PhosphorylationDTRQIQPSPPWSYDQ
CCCCCCCCCCCCCCC
27.5022115753
253PhosphorylationIQPSPPWSYDQSYQY
CCCCCCCCCCCCCCC
25.3022115753
254PhosphorylationQPSPPWSYDQSYQYL
CCCCCCCCCCCCCCC
17.7119690332
257PhosphorylationPPWSYDQSYQYLGSI
CCCCCCCCCCCCCCC
16.0028464451
258PhosphorylationPWSYDQSYQYLGSIA
CCCCCCCCCCCCCCC
8.7828464451
260PhosphorylationSYDQSYQYLGSIASP
CCCCCCCCCCCCCCC
12.5628796482
263PhosphorylationQSYQYLGSIASPSVH
CCCCCCCCCCCCCCC
16.6428796482
266PhosphorylationQYLGSIASPSVHPAT
CCCCCCCCCCCCCCC
18.9422115753
268PhosphorylationLGSIASPSVHPATPI
CCCCCCCCCCCCCCC
30.4823401153
273PhosphorylationSPSVHPATPISPGRA
CCCCCCCCCCCCCCC
26.1322115753
276PhosphorylationVHPATPISPGRASGM
CCCCCCCCCCCCCCC
23.6223401153
281PhosphorylationPISPGRASGMTTLSA
CCCCCCCCCCCHHHH
27.9526074081
284PhosphorylationPGRASGMTTLSAELS
CCCCCCCCHHHHHHH
28.2720068231
285PhosphorylationGRASGMTTLSAELSS
CCCCCCCHHHHHHHH
15.1520068231
287PhosphorylationASGMTTLSAELSSRL
CCCCCHHHHHHHHHC
20.0126074081
291PhosphorylationTTLSAELSSRLSTAP
CHHHHHHHHHCCCCC
12.6220068231
292PhosphorylationTLSAELSSRLSTAPD
HHHHHHHHHCCCCCC
50.2820068231
295PhosphorylationAELSSRLSTAPDLTA
HHHHHHCCCCCCCCC
22.7829255136
296PhosphorylationELSSRLSTAPDLTAF
HHHHHCCCCCCCCCC
46.9629255136
304PhosphorylationAPDLTAFSDPRQFPA
CCCCCCCCCCCCCCC
44.2121815630
319DimethylationLPSISDPRMHYPGAF
CCCCCCCCCCCCCCE
29.51-
319MethylationLPSISDPRMHYPGAF
CCCCCCCCCCCCCCE
29.51-
322PhosphorylationISDPRMHYPGAFTYS
CCCCCCCCCCCEECC
8.2628122231
327PhosphorylationMHYPGAFTYSPTPVT
CCCCCCEECCCCCCC
23.6626074081
328PhosphorylationHYPGAFTYSPTPVTS
CCCCCEECCCCCCCC
13.2426074081
329PhosphorylationYPGAFTYSPTPVTSG
CCCCEECCCCCCCCC
21.1746162909
331PhosphorylationGAFTYSPTPVTSGIG
CCEECCCCCCCCCCE
25.1746162933
334PhosphorylationTYSPTPVTSGIGIGM
ECCCCCCCCCCEECC
23.5726074081
335PhosphorylationYSPTPVTSGIGIGMS
CCCCCCCCCCEECCC
28.7526074081
346PhosphorylationIGMSAMGSATRYHTY
ECCCCCCCCCEECCC
17.2427251275
361O-linked_GlycosylationLPPPYPGSSQAQGGP
CCCCCCCCCCCCCCC
18.1227655845
361PhosphorylationLPPPYPGSSQAQGGP
CCCCCCCCCCCCCCC
18.1227251275
362O-linked_GlycosylationPPPYPGSSQAQGGPF
CCCCCCCCCCCCCCC
35.1427655845
362PhosphorylationPPPYPGSSQAQGGPF
CCCCCCCCCCCCCCC
35.1427251275
372PhosphorylationQGGPFQASSPSYHLY
CCCCCCCCCCCEEEE
31.8127251275
373PhosphorylationGGPFQASSPSYHLYY
CCCCCCCCCCEEEEE
22.3827251275
375PhosphorylationPFQASSPSYHLYYGA
CCCCCCCCEEEEEEC
27.4227251275
376PhosphorylationFQASSPSYHLYYGAS
CCCCCCCEEEEEECC
10.1427251275
383PhosphorylationYHLYYGASAGSYQFS
EEEEEECCCCCEEEE
28.8827251275
386PhosphorylationYYGASAGSYQFSMVG
EEECCCCCEEEEECC
18.5827251275
390PhosphorylationSAGSYQFSMVGGERS
CCCCEEEEECCCCCC
9.3126074081
397PhosphorylationSMVGGERSPPRILPP
EECCCCCCCCCCCCC
34.6526074081
406PhosphorylationPRILPPCTNASTGSA
CCCCCCCCCCCCCCH
39.3226552605
409PhosphorylationLPPCTNASTGSALLN
CCCCCCCCCCCHHCC
35.0626552605
410PhosphorylationPPCTNASTGSALLNP
CCCCCCCCCCHHCCC
32.5126552605
412PhosphorylationCTNASTGSALLNPSL
CCCCCCCCHHCCCCC
18.8126552605
418PhosphorylationGSALLNPSLPNQSDV
CCHHCCCCCCCCCCC
56.2226552605
423PhosphorylationNPSLPNQSDVVEAEG
CCCCCCCCCCEECCC
38.7330576142
431PhosphorylationDVVEAEGSHSNSPTN
CCEECCCCCCCCCCC
18.4330576142
433PhosphorylationVEAEGSHSNSPTNMA
EECCCCCCCCCCCCC
40.4730576142
435PhosphorylationAEGSHSNSPTNMAPS
CCCCCCCCCCCCCCC
35.807835892
437PhosphorylationGSHSNSPTNMAPSAR
CCCCCCCCCCCCCHH
37.1330576142
442PhosphorylationSPTNMAPSARLEEAV
CCCCCCCCHHHHHHH
19.2426552605
453PhosphorylationEEAVWRPY-------
HHHHCCCC-------
23.7126074081
458 (in isoform 2)Phosphorylation-20068231
460 (in isoform 2)Phosphorylation-20068231

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
48SPhosphorylationKinaseCDK1P06493
PSP
48SPhosphorylationKinaseCDK6Q00534
PSP
207TPhosphorylationKinasePAK4O96013
PSP
249SPhosphorylationKinaseERK-SUBFAMILY-GPS
249SPhosphorylationKinaseMAPK3P21708
GPS
249SPhosphorylationKinaseMAPK1P63086
GPS
249SPhosphorylationKinaseHIPK2Q9H2X6
Uniprot
266SPhosphorylationKinaseERK-SUBFAMILY-GPS
266SPhosphorylationKinaseMAPK3P21708
GPS
266SPhosphorylationKinaseMAPK1P63086
GPS
273TPhosphorylationKinaseHIPK2Q9H2X6
Uniprot
276SPhosphorylationKinaseCDK6Q00534
PSP
276SPhosphorylationKinaseCDK1P06493
PSP
276SPhosphorylationKinaseMAPK3P27361
GPS
276SPhosphorylationKinaseCDK2P24941
PSP
276SPhosphorylationKinaseHIPK2Q9H2X6
Uniprot
276SPhosphorylationKinaseMAPK1P28482
GPS
293SPhosphorylationKinaseCDK2P24941
PSP
293SPhosphorylationKinaseCDK1P06493
PSP
293SPhosphorylationKinaseMAPK3P27361
GPS
293SPhosphorylationKinaseMAPK1P28482
GPS
293SPhosphorylationKinaseCDK6Q00534
PSP
300TPhosphorylationKinaseMAPK1P28482
GPS
300TPhosphorylationKinaseCDK2P24941
PSP
300TPhosphorylationKinaseMAPK3P27361
GPS
300TPhosphorylationKinaseCDK1P06493
PSP
300TPhosphorylationKinaseCDK6Q00534
PSP
303SPhosphorylationKinaseMAPK1P28482
GPS
303SPhosphorylationKinaseCDK2P24941
PSP
303SPhosphorylationKinaseMAPK3P27361
GPS
303SPhosphorylationKinaseCDK6Q00534
PSP
303SPhosphorylationKinaseCDK1P06493
PSP
424SPhosphorylationKinaseCDK6Q00534
PSP
424SPhosphorylationKinaseCDK1P06493
PSP
462SPhosphorylationKinaseMAPK1P28482
GPS
462SPhosphorylationKinaseMAPK3P27361
GPS
-KUbiquitinationE3 ubiquitin ligaseCDC20Q12834
PMID:17015473
-KUbiquitinationE3 ubiquitin ligaseSTUB1Q9UNE7
PMID:19524548
-KUbiquitinationE3 ubiquitin ligaseFZR1Q9UM11
PMID:17015473

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
249SPhosphorylation

18695000
273TPhosphorylation

18695000
276SPhosphorylation

18695000

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RUNX1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PEBB_HUMANCBFBphysical
10856244
AES_HUMANAESphysical
10825294
JUN_HUMANJUNphysical
11274169
FOS_HUMANFOSphysical
11274169
VDR_HUMANVDRphysical
12460926
JUN_HUMANJUNphysical
11641401
FOS_HUMANFOSphysical
11641401
ELF4_HUMANELF4physical
10207087
ELF2_HUMANELF2physical
10207087
TLE1_HUMANTLE1physical
9751710
MTG8R_HUMANCBFA2T2physical
9447981
HIPK2_HUMANHIPK2physical
16917507
EP300_HUMANEP300physical
16917507
KAT6A_HUMANKAT6Aphysical
11742995
PEBB_HUMANCBFBphysical
11742995
HTF4_HUMANTCF12physical
15333839
TFE2_HUMANTCF3physical
15333839
MTG8_HUMANRUNX1T1physical
10882117
RUNX1_HUMANRUNX1physical
18073335
SIAH1_HUMANSIAH1physical
18073335
PML_HUMANPMLphysical
18073335
RARA_HUMANRARAphysical
18073335
HDAC2_HUMANHDAC2physical
18073335
SIN3A_HUMANSIN3Aphysical
14729951
PEBB_HUMANCBFBphysical
14729951
NR4A2_HUMANNR4A2physical
21468021
CHIP_HUMANSTUB1physical
19524548
VDR_RATVdrphysical
20236534
SMCA4_HUMANSMARCA4physical
20506188
SNF5_HUMANSMARCB1physical
20506188
SMRC1_HUMANSMARCC1physical
20506188
HDAC1_HUMANHDAC1physical
21059642
HDAC3_HUMANHDAC3physical
21059642
KMT2A_HUMANKMT2Aphysical
22012064
RBM14_HUMANRBM14physical
19585539
MTG8_HUMANRUNX1T1physical
22498736
MTG8R_HUMANCBFA2T2physical
22498736
MTG16_HUMANCBFA2T3physical
22498736
PEBB_HUMANCBFBphysical
22498736
HDAC1_HUMANHDAC1physical
22498736
HDAC2_HUMANHDAC2physical
22498736
ANM1_HUMANPRMT1physical
22498736
KAT6A_HUMANKAT6Aphysical
15331439
CBP_HUMANCREBBPphysical
15331439
PML_HUMANPMLphysical
15331439
PEBB_HUMANCBFBphysical
15331439
UXT_HUMANUXTphysical
17635584
CTBP2_HUMANCTBP2physical
17635584
NCOR2_HUMANNCOR2physical
17560331
FOXP3_HUMANFOXP3physical
17377532
RUNX1_HUMANRUNX1physical
15897867
YAP1_HUMANYAP1physical
18280240
PEBB_HUMANCBFBphysical
14752096
RAG1_HUMANRAG1physical
25135298
SPI1_HUMANSPI1physical
10207087
ELF1_HUMANELF1physical
10207087
PEBB_HUMANCBFBphysical
26598521
FACD2_HUMANFANCD2physical
25066130
PEBB_MOUSECbfbphysical
25066130

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
Note=A chromosomal aberration involving RUNX1/AML1 is a cause of M2 type acute myeloid leukemia (AML-M2). Translocation t(8
21)(q22
q22) with RUNX1T1.
601399
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RUNX1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-24 AND LYS-43, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; SER-21; SER-249;SER-266; SER-268 AND SER-276, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND SER-21, AND MASSSPECTROMETRY.
"PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 byHIPK2: implications for leukemogenesis.";
Wee H.-J., Voon D.C.-C., Bae S.-C., Ito Y.;
Blood 112:3777-3787(2008).
Cited for: PHOSPHORYLATION AT SER-249; THR-273 AND SER-276 BY HIPK2, VARIANTGLN-174, AND MUTAGENESIS OF SER-67; LYS-83; GLY-108; SER-249; THR-273AND SER-276.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND SER-21, AND MASSSPECTROMETRY.

TOP